A) List of publications in which the APOE-META-BRAIN is acknowledged.
1. Kardassis D, Amigó N, Mitić T. (2026) Limitations of current animal models in atherosclerosis: an integrative multiomics perspective. Eur
Heart J. ehaf997. doi: 10.1093/eurheartj/ehaf997. Epub ahead of print. PMID: 41556948.
2. Georgiadou D, and Chroni A. (2026) Structural and functional insights into naturally occurring apolipoprotein E variants with protective effects against Alzheimer’s disease. Int J Biol Macromol. 337(Pt 2):149644. doi: 10.1016/j.ijbiomac.2025.149644.
Epub 2025 Dec 11. PMID: 41390037
3. Karadimou G, Matic L, Magni P, Biessen EAL, Schmid JA and Kardassis D. (2026) Atherosclerotic plaque phenotypes: Unraveling complexity and heterogeneity. In: “Transcriptomics in Atherosclerosis: Deciphering Molecular Signatures and Advancing Therapeutic Strategies” Yvan Devaux, Miron Sopic Editors. Elsevier ISBN: 978-0-443-33064-3
4. Gafencu AV, Fenyo IM, Fuior EV, Dumitrescu M, Mirancea O, Multescu MG, Tudorache IF, Basılio J, Schmid JA and Kardassis D. (2026) Signaling pathways regulating gene expression in atherosclerosis. In: “Transcriptomics in Atherosclerosis: Deciphering Molecular Signatures and Advancing Therapeutic Strategies” Yvan Devaux, Miron Sopic Editors. Elsevier ISBN: 978-0-443-33064-3
5. Niculescu LS and Kardassis D. (2026) Bridging the gap in transcriptomics: From animal to human studies in atherosclerosis. In: “Transcriptomics in Atherosclerosis: Deciphering Molecular Signatures and Advancing Therapeutic Strategies” Yvan Devaux, Miron Sopic Editors. Elsevier ISBN: 978-0-443-33064-3
6. Nordestgaard LT, Wolford BN, de Gonzalo-Calvo D, Sopić M, Devaux Y, Matic L, Wettinger SB, Schmid JA, Amigó N, Masana L, Catapano AL, Kardassis D, Magni P; EU-AtheroNET COST Action CA21153 (2025) Multiomics in atherosclerotic cardiovascular disease. Atherosclerosis. 408:120414. doi: 10.1016/j.atherosclerosis.2025.120414. Epub 2025 Jun 26. PMID: 40663987.
7. Kardassis D, Vindis C, Stancu CS, Toma L, Gafencu AV, Georgescu A, Alexandru-Moise N, Molica F, Kwak BR, Burlacu A, Hall IF, Butoi E, Magni P, Wu J, Novella S, Gamon LF, Davies MJ, Caporali A, de la Cuesta F, and Mitić T. (2025) Unravelling molecular mechanisms in atherosclerosis using cellular models and omics technologies. Vascul. Pharmacol. 158:107452. doi: 10.1016/j.vph.2024.107452. Epub 2024 Dec 10. PMID: 39667548.
8. Mitić T, Georgescu A, Alexandru-Moise N, Davies MJ, Vindis C, Novella S, Gerdts E, Kararigas G, Wettinger SB, Formosa MM, Kwak BR, Molica F, Amigo N, Caporali A, de la Cuesta F, Hall IF, Chroni A, Martelli F, Schmid JA, Magni P, and Kardassis D; COST Action AtheroNET (CA21153). (2025) Current status and challenges of multi-omics research using animal models of atherosclerosis. J. Mol. Cell. Cardiol. Plus. 10;13:100476. doi: 10.1016/j.jmccpl.2025.100476. eCollection 2025 Sep. PMID: 40726539
B) Participation at national and international meeting in which the APOE-META-BRAIN is acknowledged.
1) Mountaki C., Haapasalo K. and Chroni A. Apolipoprotein E4 variants differentially affect the intraneuronal amyloid beta accumulation, tau phosphorylation and neuroinflammation in Alzheimer’s disease. 48th FEBS Congress, 29 June -3 July 2024, Milan, Italy (poster presentation) 2) Mountaki C., Dedemadi A. G. Haapasalo K., Dafnis I. and Chroni A. Distinct pathogenic roles of apolipoprotein E4 in Alzheimer’s Disease: impacts on amyloid beta intraneuronal accumulation, tau phosphorylation and neuroinflammation. 23rd Panhellenic Chemistry Conference with International Participation, 25-28 September 2024, Athens, Greece (oral presentation) 3) Georgiadou D. and Chroni A. Structural and thermodynamic analysis of Alzheimer’s disease-protective apolipoprotein E variants. 25th European Society for Neurochemistry (ESN)/ 31st Hellenic Society for Neuroscience (HSN), May 18-21 2025, Naxos, Greece (poster presentation) 4) Georgiadou D. and Chroni A. Exploring the structural and thermodynamic basis of protective effects against Alzheimer’s disease in rare apolipoprotein E variants. 6th Meeting of Young Researchers of the Hellenic Crystallographic Association, 1-2 November 2025, Athens (oral presentation) 5) Kapeta K. R., Manolis A. and Chroni A. Differential effects of dietary short-chain and palmitic fatty acids on Alzheimer’s disease-related functions of apolipoprotein E4 in brain cells. 11th Panhellenic Conference of the Working Groups of the Hellenic Society of Atherosclerosis, 5-6 December 2025, Athens (oral presentation) 6) Georgiadou D. and Chroni A. Structural and Functional Characterization of Alzheimer’s Disease-Protective Apolipoprotein E Variants. 75th Panhellenic Conference of the Hellenic Society for Biochemistry and Molecular Biology, 5-7 December 2025, Athens (oral presentation) 7) Kapeta K. R., Mountaki C. and Chroni A. Differential effects of apolipoprotein E4 variants on microglial inflammation and its modulation by short-chain fatty acids. 12th Panhellenic Conference of the Hellenic Academy of Neuroimmunology, 11-14 December 2025, Thessaloniki (poster presentation) 8) Axiotis I, Kounoupa Z, Velli A, Karantonis C, Papakosta P, Sidiropoulou K and Kardassis D. ELUCIDATING THE IMPACT OF APOLIPOPROTEIN E AND METABOLIC COMORBIDITIES ON THE PATHOGENESIS OF ALZHEIMER’S DISEASE. 11th Panhellenic Conference of the Working Groups of the Hellenic Society of Atherosclerosis, 5-6 December 2025, Athens (poster presentation) |